Dr. Reddy's QC QUALITY CHOICE allergy tablets recalled for failed dissolution specs
Dr. Reddy's QC QUALITY CHOICE extended-release allergy tablets with failed dissolution specifications are recalled. Consumers should check NDC 63868-729-10 and lot numbers 79C002624D/79C002625C.
Lower-risk recall
Failed Dissolution Specifications
Contact the company
What happened, in plain English
Dr. Reddy's QC QUALITY CHOICE allergy tablets (60mg fexofenadine and 120mg pseudoephedrine) are being recalled because they failed dissolution specifications. This means the medication may not work as intended, potentially leading to ineffective treatment. Read more at govinfonow.com/recall/35399-dr-reddy-s-qc-quality-choice-allergy-tablets-recalled-for.
Source Summary by GovInfoNow · govinfonow.com/recall/35399-dr-reddy-s-qc-quality-choice-allergy-tablets-recalled-for · Updated August 18, 2026 · FDA enforcement record: FDA #D-0384-2022
Cite this page
“Dr. Reddy's QC QUALITY CHOICE allergy tablets recalled for failed dissolution specs.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35399-dr-reddy-s-qc-quality-choice-allergy-tablets-recalled-for. Based on FDA recall #D-0384-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0384-2022%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not release the medication properly in the body. This could result in the medication not working as intended, leading to ineffective allergy treatment.
Who’s affected
People who own or use QC QUALITY CHOICE allergy tablets with NDC 63868-729-10 and lot numbers 79C002624D or 79C002625C (expired 4/30/2022) are affected. Those with allergies to fexofenadine or pseudoephedrine should avoid these products.
How to tell if you have this one
Check the product label for NDC 63868-729-10 and lot numbers 79C002624D or 79C002625C. The expiration date is 4/30/2022.
- Brand
Dr. Reddy's- Category
Drug
All 9 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Terminated- Distribution
Nationwide in the USA
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-0378-2022 | Wal-Fex D, Fexofenadine HCl 60mg/Antihistamine & Pseudoephedrine HCl 120mg/Nasal Decongestant, Extended Release Tablets USP, a) 20 Extended Release Tablets per box, NDC 0363-1606-20, b) 30 Extended Release Tablets per box, NDC 0363-1606-30, Distributed by: Walgreen Co, 200 Wilmot Rd., Deerfield, IL 60015, Made in India.; Lot #s: a) (20-count box): AC2000968D, Exp. 8/31/2022; AC2103330J, Exp. 1/31/2023; AC2106452A; AC2106452H, Exp. 3/31/2023. b) (30-count box): 79C002624C, Exp. 4/30/2022; AC2103328B; AC2103328C; AC2103330A; AC2103330B, Exp. 1/31/2023. | 67,848 boxes | 0363-1606-30, 0363-1606-20 |
| D-0379-2022 | Rugby, Antihistamine and Nasal Decongestant, Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg, Extended-Release Tablets USP, 30 Tablets per box, NDC 0536-1242-07, Distributed by: Rugby Laboratories, 17177 N Laurel Park Drive, Suite 233, Livonia, MI, 49152, Made in India.; Lot #: AC2106452F, Exp. 3/31/2023 | 2,352 boxes | — |
| D-0380-2022 | Rite Aid Pharmacy, Allergy & Congestion, Fexofenadine HCl 60mg & Pseudoephedrine HCl 120mg, Extended Release Tablets USP, 20 Extended-Release Tablets per box, UPC 011822738873, Distributed by Rite Aid, 30 United Lane, Camp Hill, PA 17011, Made in India.; Lot #: AC2103330D, Exp.1/31/2023; AC2106452E, Exp. 3/31/2023. | 7,080 boxes | — |
| D-0381-2022 | Kroger, Allergy Relief-D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine HCl 120mg/Nasal Decongestant, Extended-Release Tablets USP, 20 tablets per box, NDC 30142-611-14, Distributed by the Kroger Co., Cincinnati, Ohio, 45202, Made in India.; Lot #s: AC2000968E, Exp. 8/31/2022; AC2103328A; AC2103330I, Exp. 1/31/2023; AC2106452B, Exp. 3/31/2023. | 11,064 boxes | 30142-611-14 |
| D-0382-2022 | Dr. Reddys, Fexofenadine HCl 60 mg & Pseudoephedrine HCl 120 mg Extended-Release Tablets USP, a) 10 tablets per box, UPC 343598823355, b) 20 tablets per box, UPC 343598823140, c) 30 tablets per box, UPC 343598823317, Distributed by: Dr. Reddy's Laboratories, Inc. Princeton, NJ 08540, Made in India.; Lot #s: a) (10-count): AC2103328D, Exp. 1/31/2023. b) (20-count) :AC2000968C, Exp. 8/31/2022. c) (30-count): AC2103330C, Exp. 1/31/2023; AC2106452D, Exp. 3/31/2023. | 9,912 boxes | — |
| D-0383-2022 | equate, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine, Pseudoephedrine HCl 120mg/Nasal Decongestant Extended-Release Tablets USP, a) 20 Extended Release Tablets per box, NDC 49035-273-20, b) 30 Extended Release Tablets per box, NDC 49035-273-30, Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India.; Lot #s: a) (20-count): 79C002624A, Exp. 4/30/2022; AC2000968B, Exp. 8/31/2022; AC2103328F; AC2103330E, Exp.1/31/2023; AC2106452I, Exp. 3/31/2023. b) (30-count): 79C002625A, Exp. 4/30/2022; AC2103328E; AC2103330F, Exp. 1/31/2023; AC2106452G, Exp. 3/31/2023. | 137,856 boxes | — |
| D-0384-2022 | QC QUALITY CHOICE, Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg, Extended-Release Tablets, USP, Allergy & Congestion, 10 Tablets per box, NDC 63868-729-10, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd, Novi, MI 48375, Made in India.; Lot #s: 79C002624D; 79C002625C, Exp. 4/30/2022. | 9,984 boxes | — |
| D-0385-2022 | CVS Health, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine HCl 120mg/Nasal Decongestant, a) 20 Extended Release Tablets per box, UPC 050428436189, b) 30 Extended Release Tablets per box, UPC 050428290538, Distributed by CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI, 02895, Made in India.; Lot #s: a) (20-count): AC2000968A; AC2000968F, Exp. 8/31/2022. b) (30-count): 79C002624B, Exp. 4/30/2022; AC2103330G; AC2103330H, Exp. 1/31/2023. | 41,784 boxes | — |
| D-0386-2022 | Leader, 12HR Allergy & Congestion Relief, Fexofenadine HCl, 60mg Pseudoephedrine HCl 120mg Antihistamine Nasal Decongestant, 20 Extended Release Tablets per box, NDC 70000-0518-1, Distributed by Cardinal Health, Dublin, Ohio 43077, Made in India.; Lot #s: 79C002625B, Exp. 4/30/2022; AC2103328G, Exp. 1/31/2023; AC2106452C, Exp. 3/31/2023. | 10,536 boxes | — |
What to do — step by step
Check Product Label
Look for NDC 63868-729-10 and lot numbers 79C002624D or 79C002625C on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is there a risk of serious injury from this product?
The recall is for ineffective treatment, not a risk of serious injury. This is a low-risk issue.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0384-2022 (January 4, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0384-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.